In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Cytokinetics Inc’s stock clocked out at $51.12, up 10.17% from its previous closing price of $46.40. In other words, the price has increased by $10.17 from its previous closing price. On the day, 2.79 million shares were traded.
Ratios:
To gain a deeper understanding of CYTK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.28 and its Current Ratio is at 9.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 07, 2025, initiated with a Buy rating and assigned the stock a target price of $86.
On January 22, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $80.
On November 08, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $80.RBC Capital Mkts initiated its Outperform rating on November 08, 2024, with a $80 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Malik Fady Ibraham sold 2,000 shares for $45.98 per share. The transaction valued at 91,960 led to the insider holds 116,071 shares of the business.
Malik Fady Ibraham sold 2,000 shares of CYTK for $96,120 on Feb 04 ’25. The EVP Research & Development now owns 116,071 shares after completing the transaction at $48.06 per share. On Jan 21 ’25, another insider, Malik Fady Ibraham, who serves as the EVP Research & Development of the company, sold 2,000 shares for $45.92 each. As a result, the insider received 91,840 and left with 116,071 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1873.57.
Stock Price History:
Over the past 52 weeks, CYTK has reached a high of $81.36, while it has fallen to a 52-week low of $40.53. The 50-Day Moving Average of the stock is 7.35%, while the 200-Day Moving Average is calculated to be -3.56%.
Shares Statistics:
A total of 117.89M shares are outstanding, with a floating share count of 114.49M. Insiders hold about 2.98% of the company’s shares, while institutions hold 109.87% stake in the company.
